Zeid, Silav
Buch, Gregor
Velmeden, David
Söhne, Jakob
Schulz, Andreas
Schuch, Alexander
Tröbs, Sven-Oliver
Heidorn, Marc William
Müller, Felix
Strauch, Konstantin
Coboeken, Katrin
Lackner, Karl J.
Gori, Tommaso
Münzel, Thomas
Prochaska, Jürgen H.
Wild, Philipp S. http://orcid.org/0000-0003-4413-9752
Clinical trials referenced in this document:
Documents that mention this clinical trial
Heart rate variability: reference values and role for clinical profile and mortality in individuals with heart failure
https://doi.org/10.1007/s00392-023-02248-7
Funding for this research was provided by:
Deutsches Zentrum für Herz-Kreislaufforschung (81Z0210102)
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Received: 21 September 2022
Accepted: 19 June 2023
First Online: 9 July 2023
Declarations
:
: P.S.W. reports for the submitted work grants from Bayer AG. Outside the submitted work, he reports on non-financial grants from Philips Medical Systems, grants and consulting fees from Boehringer Ingelheim, grants and consulting fees from Novartis Pharma, grants and consulting fees from Sanofi-Aventis, grants, consulting and lecturing fees from Bayer Health Care, grants and consulting fees from Daiichi Sankyo Europe, lecturing fees from Pfizer Pharma, lecturing fees from Bristol Myers Squibb, consulting fees from Astra Zeneca, consulting fees and non-financial support from Diasorin and non-financial support from I.E.M. P.S. Wild is principal investigator of the German Center for Cardiovascular Research (DZHK) and principal investigator of the DIASyM research core (BMBF DIASyM research core (BMBF 031L0217A) P.S. Wild was funded by the Ministry of Education and Research (BMBF 01EO1003 and 01EO1503). J.H.P. has received honoraria for lectures from Bayer AG, Boehringer Ingelheim, Daiichi Sankyo GmbH, and Sanofi-Aventis GmbH as well as research grants from the Federal Ministry of Education and Research (BMBF 01EO1503) and the German Center for Cardiovascular Research (DZHK) outside the topic of the present study. K.C. is an employee of Bayer AG. S.O.T. has received personal fees from Philips Health Care for a lecture outside the submitted work and is an employee of Boehringer Ingelheim and University Medical Center Mainz.
: The local data protection officer and the responsible ethics committee approved the study protocol [reference number 837.319.12 (8420-F)] prior to study initiation. All study participants provided written informed consent prior to study enrolment. The Declaration of Helsinki [CitationRef removed] and the recommendations of good clinical practice and good epidemiological practice were followed in all study procedures.
: Not applicable.